Giant Biogene Holding Financial Health
Financial Health criteria checks 6/6
Giant Biogene Holding has a total shareholder equity of CN¥2.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.1B and CN¥301.2M respectively. Giant Biogene Holding's EBIT is CN¥1.1B making its interest coverage ratio -86.2. It has cash and short-term investments of CN¥2.2B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -86.2x |
| Cash | CN¥2.22b |
| Equity | CN¥2.84b |
| Total liabilities | CN¥301.19m |
| Total assets | CN¥3.14b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 2367's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥280.9M).
Long Term Liabilities: 2367's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥20.3M).
Debt to Equity History and Analysis
Debt Level: 2367 is debt free.
Reducing Debt: 2367 has not had any debt for past 5 years.
Debt Coverage: 2367 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2367 has no debt, therefore coverage of interest payments is not a concern.